|
Profile of patients having pelvic inflammatory disease and prevalence of Chlamydia trachomatis infection in the symptomatic women attending Gynecology unit in a tertiary center
Johri Taarini1, Parmar Vaibhav1, Makrani Moin1, Mahida Aarti1, Kanugo Aakas1, Pandya Himani2
1 Student, Smt. B. K. Shah Medical Institute and Research Center, Sumandeep Vidyapeeth, Piparia, Waghodia, Vadodara, Gujarat, India
2 Tutor, Department of Microbiology, Smt. B. K. Shah Medical Institute and Research Center, Sumandeep Vidyapeeth, Piparia, Waghodia, Vadodara, Gujarat, India
Correspondence Address:
Pandya Himani
Tutor, Department of Microbiology, Smt. B. K. Shah Medical Institute and Research Center, Sumandeep Vidyapeeth, Piparia, Waghodia, Vadodara, Gujarat
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/2347-6486.240197
|
|
Introduction: Chlamydia trachomatis is one of the causes of sexually transmitted bacterial disease (STD’s) causing genital infection in the world. Many countries have expanded the strategies to investigate, diagnose and manage this curable, but prevalent and indolent disease. Most severe consequence in women is pelvic inflammatory disease (PID) and infertility. This study was designed to detect Chlamydia trachomatis infection and to correlate the infection with various risk factors in the symptomatic females attending the gynecology OPD at Dhiraj Hospital, Piparia, Vadodara, Gujarat, India
Methodology: From September 2016 to November 2016, 50 consecutive symptomatic women of reproductive age were screened for the presence of Chlamydia antigen. Endocervical swabs were collected and tested using Immunochromatographic immunoassay.
Results: The limited number of cases of infertility and PID investigated did not reveal any positive case of Chlamydia antigen from endocervical swabs.
Conclusion: Accurate diagnostic tests like NAAT and ELISA are required instead of point-of-care test to prove its role in PID and infertility.
|
